Parse Biosciences is a global life sciences company accelerating progress in human health and scientific research through single cell sequencing. Founded on technology from the University of Washington, the company has raised over $100 million and is used by over 3,000 labs worldwide, with a growing portfolio of products and a new headquarters in Seattle.